As of 11:25am ET
| -0.02 / -1.56%|
The 3 analysts offering 12-month price forecasts for Biocept Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 1.80. The median estimate represents a +98.41% increase from the last price of 1.26.
The current consensus among 3 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.